CLEC10A Antikörper

Produktnummer ABIN2664536

Produktdetails anti-CLEC10A Antikörper

Target: CLEC10A (C-Type Lectin Domain Family 10, Member A (CLEC10A))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CLEC10A Antikörper ist unkonjugiert

Applikation: ELISA (Capture)

Aufreinigung: The antibody was purified by affinity chromatography.

Klon: H037G3

Isotyp: IgG2a kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.5 mg/mL

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: The antibody solution should be stored undiluted between 2°C and 8°C.

Details zu CLEC10A

Target: CLEC10A (C-Type Lectin Domain Family 10, Member A (CLEC10A))

Andere Bezeichnung: CD301 (CLEC10A Produkte)

Synonyme: CLEC10A antikoerper, CD301 antikoerper, CLECSF13 antikoerper, CLECSF14 antikoerper, HML antikoerper, HML2 antikoerper, MGL antikoerper, CD301a antikoerper, M-ASGP-BP-1 antikoerper, Mgl antikoerper, Mgl1 antikoerper, Mgll antikoerper, C-type lectin domain family 10 member A antikoerper, C-type lectin domain containing 10A antikoerper, C-type lectin domain family 10, member A antikoerper, LOC607405 antikoerper, CLEC10A antikoerper, Clec10a antikoerper

Hintergrund: CD301, also known as CLEC10A, macrophage galactose/N-acetylgalactosamine (GalNAc) specific lectin (MGL), DCASGPR, and HML, is a 40 kD type II transmembrane glycoprotein, which belongs to the C-type lectin family. Human CD301 consists of a 39 amino acid (aa) cytoplasmic region, a 21 aa transmembrane segment, and a 256 aa extracellular domain (ECD) with one carbohydrate recognition domain (CRD) and a neck region. CD301 is expressed on immature myleloid dendritic cells and alternatively activated (tolerogenic) macrophages. The expression level is upregulated by immunosuppressant dexamethasone. Human CD301 has an exclusive specificity for rare terminal GalNAc structures, which are revealed on the tumor-associated mucin MUC1 and CD45 (RA, RB, and RC but not RO isoforms). This interaction inhibits effector T cell activation and induces their apoptosis. CD301 also binds the GP envelope glycoprotein on Marburg and Ebola viruses and enhances viral entry and infectivity.